Outsourcing

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Articles

CMOs Plan for Capacity Expansions

Representatives of contract service organizations that specialize in parenteral drug development and manufacturing describe the evolving trends.

CMOs Target Parenteral Drug Development Needs Both Large and Small

Contract development and manufacturing organizations identify trends, challenges, and emerging technology and service needs for solid and semi-solid dosage forms.

Solid-Dosage Forms Demand Traditional and Emerging Technologies

Recipharm has invested EUR 32 million ($43 million) in its Wasserburg, Germany site to expand lyophilization capacity.

Recipham to Expand Lyophilization Capacity in Germany

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Jim Miller, president of PharmSource, examines the future direction of CROs/CMOs and the factors influencing the pharmaceutical contract services sectors.

Contract Manufacturing, Finished Drug Product